CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Press Statement

A report released today by the U.S. National Academies of Sciences and Medicine and the U.K. Royal Society lays out a road map to clinical uses of heritable genome editing – that is, altering the genes and traits of future...

Biopolitical Times
Writing in the pages of The New York Times, Harvard Business School professor Debora Spar argues that a coming technological breakthrough – in vitro gametogenesis, or gametes manufactured from ordinary body cells – will herald a “revolution” that will “dismantle completely the reproductive structure of heterosexuality.”

Op-Ed

In this interview as in past public comments, Jennifer Doudna opens the door to using the CRISPR platform she helped...

Biopolitical Times
We are in a moment of extreme challenge for each of us and for our country's future – yet again....

Biopolitical Times

On September 3rd, Heritable Human Genome Editing was published. This Report was the work of a multinational Commission organized...

In August 1964, the North Carolina Eugenics Board met to decide if a 20-year-old Black woman should be sterilized. Because...

Writing in the pages of The New York Times, Harvard Business School professor Debora Spar argues that a coming technological...

News

In 2004, California voters agreed to borrow $3 billion to bankroll a stem-cell research program dedicated to seeking cures for cancer, Alzheimer’s and other debilitating diseases.

TV ads featured Michael J. Fox, who has Parkinson’s, and the late Christopher Reeve,...

The Consensus Study Report of the International Commission on the Clinical Use of Human Germline Genome Editing convened by the US National Academies of Medicine and Sciences and the UK’s Royal Society was published on 3 September.

Heritable human genome...

Poor laboratory practices at a Boston company that performed Covid-19 tests for dozens of nursing homes in Massachusetts put patients at risk of harm, state public-health officials said.

On Friday, Bloomberg News reported that the company, Orig3n Inc., was...

California's 21 million voters soon will be receiving mail that tells them a $5.5 billion stem cell ballot measure is "outrageous," unaffordable and will perpetuate long-standing problems with the state's stem cell research program.

Video

Future of Genetics | FULL DEBATE | Doha Debates
Bill McKibben and john a. powell discuss “Climate Crisis, Designer Babies, and Our Common Future.”
A Reading and Discussion with George Estreich